Research Group Complex Diseases (CD)

Our research objective is the genetic, epigenetic, and functional analysis of complex diseases, such as cardiovascular and metabolic conditions, and their intermediate phenotypes. We use epidemiological methods to study the complex interplay between molecular mechanisms and environmental factors (such as smoking) in relation to the onset and progression of disease. Identified loci are subjected to further functional characterization.

We have particular experience in conducting high-throughput genotyping and genome-wide methylation projects. The group is part of the Genome Analysis Center (GAC), a high-throughput genotyping platform offering several state-of-the-art laboratory technologies (MALDI-TOF MS, Affymetrix, Illumina), techniques enabling the generation of high-dimensional omics data for the investigation of complex diseases. Additionally, we have established a functional pipeline using molecular biology and cell culture-based techniques for functional in vitro and in vivo characterization of SNP and methylation effects.

Team of Research Group "Complex Diseases" at Chiemsee/Bavaria

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.